To investigate this, we treated H929 and 8226 MM cell lines with the CARM1 inhibitor, EZM2302, alone and together with IKZF3-targeting pomalidomide or lenalidomide for 6 days. Here, IKZF3 is linked to Miyoshi myopathy.